Table 2.
Outcome/risk factor | Sample | OR (95% C.I.) |
p-value | Corrected p-valuec | |
---|---|---|---|---|---|
Unadjusteda | Adjusted for sex, ethnicity, social class and BMIb | ||||
Definite PEs | |||||
PRS-T2DM | 3768 | 1.15 (0.99–1.34) | 1.21 (1.01–1.45) | 0.027 | 0.054 |
Psychotic disorder | |||||
PRS-T2DM | 3768 | 1.42 (1.00–1.96) | 1.51 (1.04–2.05) | 0.016 | 0.048⁎ |
Insulin resistance | |||||
PRS-SCZ | 2344 | 1.16 (1.04–1.32) | 1.10 (0.99–1.22) | 0.089 | 0.089 |
Unadjusted analysis adjusted for 10 principal components only.
Samples for adjusted analysis included 3070 participants for psychotic outcomes and 1970 participants for insulin resistance outcome.
p-value corrected from adjusted analysis using Holm-Bonferroni method.
Evidence surpasses Holm-Bonferroni threshold.